CLEARPOINT NEURO INC's ticker is CLPT and the CUSIP is 18507C103. A total of 64 filers reported holding CLEARPOINT NEURO INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,605 | +25.1% | 18,484 | +80.8% | 0.00% | – |
| Q2 2023 | $74,029 | -45.5% | 10,225 | -36.5% | 0.00% | – |
| Q1 2023 | $135,808 | +286.0% | 16,091 | +287.4% | 0.00% | – |
| Q4 2022 | $35,185 | -33.6% | 4,154 | -18.8% | 0.00% | – |
| Q3 2022 | $53,000 | -43.6% | 5,118 | -28.6% | 0.00% | – |
| Q2 2022 | $94,000 | -43.4% | 7,166 | -55.0% | 0.00% | – |
| Q1 2022 | $166,000 | -43.5% | 15,914 | -39.2% | 0.00% | – |
| Q4 2021 | $294,000 | +77.1% | 26,162 | +179.6% | 0.00% | – |
| Q3 2021 | $166,000 | -2.9% | 9,358 | +4.5% | 0.00% | – |
| Q2 2021 | $171,000 | +90.0% | 8,957 | +109.9% | 0.00% | – |
| Q1 2021 | $90,000 | +73.1% | 4,267 | +31.3% | 0.00% | – |
| Q4 2020 | $52,000 | +173.7% | 3,250 | -6.4% | 0.00% | – |
| Q3 2020 | $19,000 | +58.3% | 3,471 | +0.4% | 0.00% | – |
| Q2 2020 | $12,000 | 0.0% | 3,456 | +5.7% | 0.00% | – |
| Q1 2020 | $12,000 | – | 3,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parian Global Management LP | 678,999 | $12,962,000 | 5.56% |
| Taylor Frigon Capital Management LLC | 175,690 | $3,354,000 | 1.05% |
| Mayo Clinic | 38,114 | $728,000 | 0.80% |
| APIS CAPITAL ADVISORS, LLC | 40,000 | $764,000 | 0.66% |
| Blackcrane Capital, LLC | 27,653 | $528,000 | 0.64% |
| Parian Global Management LP | 75,000 | $1,432,000 | 0.62% |
| Triumph Capital Management | 29,509 | $500,000 | 0.29% |
| AlphaCentric Advisors LLC | 50,000 | $955,000 | 0.26% |
| KIRR MARBACH & CO LLC /IN/ | 45,200 | $863,000 | 0.24% |
| Kepos Capital LP | 125,000 | $2,386,000 | 0.18% |